Investors chew on Jaws’ stunning $4.4bn SPAC deal for Cano Health

The deal highlights the fact that PIPE investors in a SPAC are underwriting to different financial metrics than prospective PE buyers – leading to much larger valuations in some cases.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


New to PE Hub?

Register now to read this article and more for free.